Search Results - "Morris, Beth A."

Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine by Lipton, Richard B, Croop, Robert, Stock, Elyse G, Stock, David A, Morris, Beth A, Frost, Marianne, Dubowchik, Gene M, Conway, Charles M, Coric, Vladimir, Goadsby, Peter J

“…Treatment with the oral calcitonin gene–related peptide receptor antagonist rimegepant resulted in freedom from migraine pain 2 hours after the dose in 20% of…”
Get full text

Effect of Decreasing County Mental Health Services on the Emergency Department by Nesper, Arica C., MD, MAS, Morris, Beth A., MPH, Scher, Lorin M., MD, Holmes, James F., MD, MPH

“…Study objective We evaluate the effect of decreasing county mental health services on the emergency department (ED). Methods This is a retrospective…”
Get full text

No clinically relevant electrocardiogram effects in a randomized TQT study of single therapeutic/supratherapeutic rimegepant doses in healthy adults by Bhardwaj, Rajinder, Hanna, Michael S., Morris, Beth A., Matschke, Kyle T., Bertz, Richard, Croop, Robert S., Liu, Jing

“…A single‐center, phase I, partially double‐blind (double‐blind regarding doses of rimegepant and placebo, and open label with respect to moxifloxacin),…”
Get full text

Concentration‐QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval by Hughes, Jim H., Bertz, Richard, Bhardwaj, Rajinder, Donohue, Mary K., Madonia, Jennifer, Anderson, Matt S., Morris, Beth A., Croop, Robert S., Liu, Jing

“…Zavegepant is a novel gepant administered as a nasal spray approved in the United States at a 10 mg dose for the acute treatment of migraine with or without…”
Get full text

Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials by Lipton, Richard B, Blumenfeld, Andrew, Jensen, Christopher M, Croop, Robert, Thiry, Alexandra, L'Italien, Gilbert, Morris, Beth A, Coric, Vladimir, Goadsby, Peter J

“…This post-hoc analysis from three phase 3 treatment trials of rimegepant 75 mg - an oral small molecule calcitonin gene-related peptide receptor antagonist for…”
Get more information

Efficacy and Safety of Rimegepant 75 mg Oral Tablet, a CGRP Receptor Antagonist, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial by Lipton, Richard B, Thiry, Alexandra, Morris, Beth A, Croop, Robert

“…This study compared the efficacy, tolerability, and safety of rimegepant 75 mg oral tablet - a small molecule calcitonin-gene receptor peptide (CGRP) receptor…”
Get full text

The Impact of Inpatient Boarding on ED Efficiency: A Discrete-Event Simulation Study by Bair, Aaron E., Song, Wheyming T., Chen, Yi-Chun, Morris, Beth A.

“…In this study, a discrete-event simulation approach was used to model Emergency Department’s (ED) patient flow to investigate the effect of inpatient boarding…”
Get full text

Variation in specialists' reported hospitalization practices of children sustaining blunt abdominal trauma by Sokolove, Peter E, Kuppermann, Nathan, Vance, Cheryl W, Lee, Moon O, Morris, Beth A, Holmes, James F

“…Children with blunt abdominal trauma (BAT) are often hospitalized despite no intervention. We identified factors associated with emergency department (ED)…”
Get full text

Variation in specialists' reported hospitalization practices of children sustaining blunt head trauma by Vance, Cheryl W, Lee, Moon O, Holmes, James F, Sokolove, Peter E, Palchak, Michael J, Morris, Beth A, Kuppermann, Nathan

“…Questions surround the appropriate emergency department (ED) disposition of children who have sustained blunt head trauma (BHT). Our objective was to identify…”
Get full text

Community-Based Education and Service: The Hpsisn Experience by Gelmon, Sherril B., Holland, Barbara A., Shinnamon, Anu F., Morris, Beth A.

“…Health services delivery is increasingly shifting to community-based settings. The competencies required of future health professionals require a shift in…”
Get full text